Variability in Human Immunodeficiency Virus infection screening: impact of the COVID-19 pandemic.

Q3 Medicine
Maximiliano Gabriel Castro, María José Sadonio, Ana Verónica Willa, Micaela Capeletti, Ana Paula Amato, Guillermina Cravero, Melina Beloso, Federico Rafael Galluccio
{"title":"Variability in Human Immunodeficiency Virus infection screening: impact of the COVID-19 pandemic.","authors":"Maximiliano Gabriel Castro, María José Sadonio, Ana Verónica Willa, Micaela Capeletti, Ana Paula Amato, Guillermina Cravero, Melina Beloso, Federico Rafael Galluccio","doi":"10.31053/1853.0605.v82.n2.46015","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Due to potential disruptions in HIV care services caused by COVID-19, this study aimed to evaluate the variability in HIV screening between 2019 and 2022 among adults hospitalized in the general ward of a tertiary care hospital in Santa Fe.</p><p><strong>Materials and methods: </strong>This ambispective and observational study evaluated the request for HIV serologic screening in patients selected through randomized sampling at a 2:1 ratio from October to December of the years 2019 to 2022. The impact of the COVID-19 pandemic during 2020 was compared to 2019, followed by the impact of an institutional intervention aimed at increasing the rate of HIV screening requests.</p><p><strong>Results: </strong>A total of 995 subjects were included. HIV screening was requested for 47.4% (n=472) of them, with a positivity rate of 1.7% (n=8). In 2020, HIV screening decreased compared to 2019 (34% vs. 43.9%, p<0.001), and increased to 84.2% in 2022 (p<0.001). In the multivariate analysis, the odds of HIV screening decreased with age (OR 0.986), while hospital admission in 2019 and 2022 (OR 1.48 y 9.76, respectively) increased it.</p><p><strong>Discussion: </strong>The COVID-19 pandemic exacerbated the already low rate of HIV screening requests, which was also influenced by the age of the subjects. However, through institutional guidelines, this situation was successfully reversed in 2022.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 2","pages":"237-252"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista de la Facultad de Ciencias Medicas de Cordoba","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31053/1853.0605.v82.n2.46015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Due to potential disruptions in HIV care services caused by COVID-19, this study aimed to evaluate the variability in HIV screening between 2019 and 2022 among adults hospitalized in the general ward of a tertiary care hospital in Santa Fe.

Materials and methods: This ambispective and observational study evaluated the request for HIV serologic screening in patients selected through randomized sampling at a 2:1 ratio from October to December of the years 2019 to 2022. The impact of the COVID-19 pandemic during 2020 was compared to 2019, followed by the impact of an institutional intervention aimed at increasing the rate of HIV screening requests.

Results: A total of 995 subjects were included. HIV screening was requested for 47.4% (n=472) of them, with a positivity rate of 1.7% (n=8). In 2020, HIV screening decreased compared to 2019 (34% vs. 43.9%, p<0.001), and increased to 84.2% in 2022 (p<0.001). In the multivariate analysis, the odds of HIV screening decreased with age (OR 0.986), while hospital admission in 2019 and 2022 (OR 1.48 y 9.76, respectively) increased it.

Discussion: The COVID-19 pandemic exacerbated the already low rate of HIV screening requests, which was also influenced by the age of the subjects. However, through institutional guidelines, this situation was successfully reversed in 2022.

人类免疫缺陷病毒感染筛查的变异性:COVID-19大流行的影响
导语:由于COVID-19可能导致艾滋病毒护理服务中断,本研究旨在评估2019年至2022年在圣达菲一家三级医院普通病房住院的成年人艾滋病毒筛查的变异性。材料与方法:本双侧观察性研究评估了2019年10月至2022年12月以2:1的比例随机抽样的患者对HIV血清学筛查的要求。将2020年COVID-19大流行的影响与2019年进行比较,然后是旨在提高艾滋病毒筛查请求率的机构干预的影响。结果:共纳入995名受试者。其中47.4% (n=472)人要求进行HIV筛查,阳性检出率为1.7% (n=8)。与2019年相比,2020年艾滋病毒筛查率下降(34%对43.9%)。讨论:COVID-19大流行加剧了本已较低的艾滋病毒筛查请求率,这也受到受试者年龄的影响。然而,通过制度指导,这种情况在2022年成功扭转。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.60
自引率
0.00%
发文量
60
审稿时长
20 weeks
期刊介绍: The Journal of the Faculty of Medical Sciences is a scientific publication of the Secretariat of Science and Technology of the Faculty of Medical Sciences of the National University of Cordoba. Its objective is to disseminate and promote research work related to Medical and Biological Sciences. It publishes scientific works of national and international professionals on different topics related to health sciences from the field of medicine, nursing, kinesiology, diagnostic imaging, phonoaudiology, nutrition, public health, chemical sciences, dentistry and related.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信